PolyPid Ltd (POLY) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Summary

PolyPid Ltd (PolyPid) is a pharmaceutical company that develops manufactures and commercializes therapies for the treatment of various medical conditions including infection, pain, inflammation and cancer. The companys pipeline product candidates include D-Plex100, an antibiotic drug reservoir that is implanted during surgery to prevent and treat surgical site infections; D-PLEX1000, a product candidate used in orthopedic surgeries for the prevention of surgical site infections and support of bone recovery; and D-PLEX500 for use in periodontal and oral or maxillofacial surgeries to treat peri-implantitis. It develops its products using polymer-lipid encapsulation matrix technology. The company collaborates with pharmaceutical and biotechnology companies through licensing and collaboration agreements for the encapsulation of their drugs including peptides, proteins and antibodies. PolyPid is headquartered in Petach Tikva, Israel.

PolyPid Ltd (POLY) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

it derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and co